medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2014, Number 3

<< Back Next >>

Alerg Asma Inmunol Pediatr 2014; 23 (3)

Influenza: Why the need for a quadrivalent vaccine against influenza?

Hernández M, Barahona G, González N, Palacio P

Language: Spanish
References: 9
Page: 39-46
PDF size: 306.17 Kb.


ABSTRACT

The influenza virus has accompanied humanity since ancient times causing major epidemics and pandemics as the most recent occurred in 2009 (H1N1) that caused 575,000 deaths. It is one of the most contagious diseases by its high mutation capacity (antigenic Drift and Shit) mostly affect the extremes of life (‹ 5 years and › 65 years). The peaks of influenza occur in Mexico from November to May, but on average are more often in January or February. Clinical manifestations vary according to age and comorbidities. The most effective method to prevent infection is annual vaccination. However, given the epidemiological patterns of recent years which have appeared influenza B Yamagata and Victoria, where there is no concordance in previous annual periods up to 50-75% of cases of influenza B reported. Additionally, where the impact of influenza B disease is most evident in children under 6 years is necessary to include a quadrivalent vaccine containing two hemagglutinin A and two hemaglutinas B.


REFERENCES

  1. Carr S. Seasonal and pandemic influenza: an overview with pediatric focus. Adv Pediatr. 2012; 59 (1): 75-93.

  2. Bridges B et al. En: Plotkin SA, Orenstein WA (Eds). Vaccines. 5th. edition. Philadelphia: Saunders; 2008: pp. 259-290.

  3. Derlet RW, Cunha BA. Influenza. Medscape. Drugs, Diseases & Procedures. 2103.

  4. Glezen WP, Couch RB, MacLean RA et al. Interpandemic influenza in the Houston area, 1974-76. N Engl J Med. 1978; 298: 587-592.

  5. Consejo de Salubridad General. Prevención, diagnóstico y tratamiento de influenza estacional. GPC. 2011.

  6. MMWR. Centers for disease control and prevention. 2011; 60 (1).

  7. Karadag-Oncel E, Ceyhan M. Oseltamivir en neonates, infants and young children: a focus on clinical pharmacology. Infectious Disorders. 2013; 13: 15-24.

  8. American Academy of Pediatrics Committee of Infectious Diseases. Recommendations for prevention and control of influenza in children, 2011-2012. Pediatrics. 2011; 128: 813-825.

  9. [acceso 14 de agosto de 2013] Disponible en: http://www.cdc.gov/flu/professionals/acip/2013-summary-recommendations.htm?s_cid=seasonalflu-govd-003.




2020     |     www.medigraphic.com